31 oct
|
Alexion, AstraZeneca Rare Disease
|
Barcelona
31 oct
Alexion, AstraZeneca Rare Disease
Barcelona
Lead general market access, pricing, and reimbursement strategies for rare neurology diseases, focusing on NMOSD indication. Drive value proposition and evidence generation to ensure patient access to transformative therapies.
📌 Global Pricing & Access Lead, Rare Neurology (Barcelona)
🏢 Alexion, AstraZeneca Rare Disease
📍 Barcelona